On Wednesday, TriMas got an upgrade for its IBD SmartSelect Composite Rating from 94 to 97.
Looking For The Best Stocks To Buy And Watch? Start Here
The upgrade means the stock is now outperforming 97% of all other stocks in terms of key performance metrics and technical strength. History shows the top market performers tend to have a 95 or higher score as they launch their major climbs.
TriMas has now climbed above a proper buy zone after breaking out from a 28.51 buy point in a consolidation.
The stock has an 87 EPS Rating, meaning its recent quarterly and longer-term annual earnings growth is outpacing 87% of all stocks.
Its Accumulation/Distribution Rating of A shows heavy buying by institutional investors, such as mutual funds and pension funds, over the last 13 weeks.
In Q2, the company posted 42% earnings-per-share growth. That marks three straight quarters of rising EPS performance. Revenue growth increased 14%, up from 6% in the prior report. That marks one quarter of accelerating revenue gains.
TriMas holds the No. 1 rank among its peers in the Diversified Operations industry group. Crane and Emerson Electric are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
